Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...
More than 400 cartons of Nilotinib capsules were voluntarily recalled by Cipla USA after failing manufacturing specifications ...
Cipla USA, a subsidiary of the Indian drugmaker, is recalling over 400 cartons of generic anti-cancer drug Nilotinib due to a manufacturing issue. The recall is classified as Class III by the USFDA, ...
Cipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing issue where the capsules failed to meet specifications. This is a voluntary ...
News-Medical.Net on MSN
Remote ischemic conditioning shields the heart from chemotherapy damage
Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...
Cipla USA is voluntarily recalling over 400 cartons of its anti-cancer drug, Nilotinib Capsules, due to a manufacturing issue.
A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medication from the American market after a manufacturing-related issue was detected, according to the US ...
A study, published in Basic Research in Cardiology, demonstrates in an experimental model that the heart can be protected during anthracycline treatment using a simple, non-pharmacological technique ...
Celltrion aims to join the global race for obesity drugs with an oral pill and an injection for supporting weight loss, the ...
Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...
Cipla recalls over 400 cartons of Nilotinib cancer medication in the U.S. due to manufacturing specification issues, USFDA reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results